<--- Back to Details
First PageDocument Content
Dimethyl sulfoxide / Leukapheresis / CSL Behring / Apheresis / Matter / Hematology / Transfusion medicine / Cryopreservation
Date: 2013-10-20 08:00:47
Dimethyl sulfoxide
Leukapheresis
CSL Behring
Apheresis
Matter
Hematology
Transfusion medicine
Cryopreservation

SOP: Cryopreservation of hematopoietic cells from human leukapheresis product SOP: Date modified: Modified by:

Add to Reading List

Source URL: www.roadmapepigenomics.org

Download Document from Source Website

File Size: 79,12 KB

Share Document on Facebook

Similar Documents

Sickle cell disease and hyperhemolysis: epidemiology, risk factors and new therapeutic approaches in France WORLD APHERESIS ASSOCIATION AND FRENCH SOCIETY FOR HEMAPHERESIS April 27-29, 2016, PARIS-FRANCE

Sickle cell disease and hyperhemolysis: epidemiology, risk factors and new therapeutic approaches in France WORLD APHERESIS ASSOCIATION AND FRENCH SOCIETY FOR HEMAPHERESIS April 27-29, 2016, PARIS-FRANCE

DocID: 1sjCl - View Document

Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age  Making an apheresis donation is

Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age Making an apheresis donation is

DocID: 1rrmk - View Document

S7 KHOEL Manual exchanges WAA

S7 KHOEL Manual exchanges WAA

DocID: 1rnBM - View Document

HemaT symposium Rheopheresis and distal arteriopathy [Mode de compatibilité]

HemaT symposium Rheopheresis and distal arteriopathy [Mode de compatibilité]

DocID: 1rnak - View Document

Prediction Algorithms for Cell Therapy Collections, J. Roig WAA 2016

Prediction Algorithms for Cell Therapy Collections, J. Roig WAA 2016

DocID: 1rhi1 - View Document